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Clinical Implications
•	 In	2002,	8200	adults	per	100	000	living	in	Alberta	misused	1	or	more	prescription	
drugs	in	the	preceding	12	months.	Estimates	suggest	PDM	has	increased	since	that	
time.
•	 Disabled	status	was	the	strongest	overall	predictor	of	past-year	PDM.
•	 Problem	gambling	in	the	preceding	12	months	was	the	strongest	addiction-related	
predictor	of	PDM,	followed	by	12-month	cocaine	or	crack	use	and	12-month	alcohol	
dependence.
Limitations
•	 The	study	design	was	cross-sectional.
•	 Data	on	prescription	drug	use	and	motives	for	misuse	were	not	collected.
•	 The	sample	size	precluded	a	detailed	analyses	of	prescription	misuse	by	drug	class.
Key Words: prescription drug misuse, problem gambling, illicit drug use, alcohol 
dependence, smoking, population-based adults, Canada
Prevalence and Correlates of 12-Month Prescription 
Drug Misuse in Alberta
Cheryl L Currie, PhD Candidate1; Donald P Schopflocher, PhD2; T Cameron Wild, PhD3
Objective:	We	examined	the	prevalence	and	correlates	of	prescription	drug	misuse	(PDM)	in	
a	population-based	sample	of	adults	from	Alberta.
Methods:	Data	were	collected	from	3511	adults	in	Alberta	aged	18	years	and	older	in	2002	
using	a	computer-aided	telephone	survey;	the	survey	response	rate	was	57.4%.
Results:	The	prevalence	of	12-month	PDM	in	Alberta	was	8.2%	in	2002.	Opiates	were	the	
most	frequently	misused	drug	class,	followed	by	sedatives,	stimulants,	and	tranquilizers.	
Current	disability	was	particularly	associated	with	PDM.	Odds	of	PDM	were	also	elevated	
among	adult	students	and	adults	with	a	high	school	diploma	relative	to	adults	with	a	post-
secondary	degree.	Past-year	problem	gambling,	illicit	drug	use,	and	alcohol	use	and	
dependence	were	each	associated	with	PDM,	while	past-year	binge	drinking	and	daily	
smoking	were	not.
Conclusions:	Findings	suggest	PDM	was	an	important	public	health	concern	in	Alberta	
in	2002.	Estimates	suggest	prescription	use	and	misuse	have	increased	substantially	in	
Canada	since	that	time.	There	is	an	urgent	need	for	an	ongoing	assessment	of	this	evolving	
problem	so	that	effective	prevention	and	therapeutic	strategies	can	be	developed.
Can	J	Psychiatry.	2011;56(1):27–34.
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Increases in the production and use of psychoactive pharmaceutical drugs in North America have led to 
concerns about PDM and its consequences including injury, 
dependence, mood changes, fatal and nonfatal overdoses, cardiac 
arrhythmias, and respiratory depression.1–5 Research suggests 
the most abused pharmaceutical preparations are those most 
potent and most available in the licit market.6–10 In the United 
States, PDM has risen steadily since the mid-1990s to become 
the second most abused category of psychoactive drugs 
after cannabis.9,11,12 People at greatest risk may be those who 
engage in other addictive behaviours. Researchers have 
just begun to describe the co-occurrence of PDM and other 
substance use problems, while potential associations between 
PDM and problem gambling remain virtually unknown.2,12–14
Canada is the world’s top per capita consumer of several high-
potency opioids (for example, hydromorphone) and among the 
heaviest consumers of prescription medications in the world.9 
Nevertheless to date, little epidemiologic information is 
available about the misuse of psychoactive prescription drugs 
in this country despite calls for a systematic assessment of 
this evolving problem.15 Findings released from the Canadian 
Alcohol and Drug Use Monitoring Survey indicate that of the 
28.4% of Canadians who used a psychoactive pharmaceutical 
drug in 2008, only 2% did so to get high.16 There are additional 
reasons prescription drugs may be misused, including 
therapeutic effects (for example, to relieve pain or to sleep), 
to counteract the effects of other drugs, or to experiment; all 
of which may also be of clinical significance given they fall 
outside medically sanctioned use and may endanger public 
health. In our study, PDM was defined by prescription status 
(that is, medically sanctioned, compared with unsanctioned, 
use). Specifically, PDM was defined as use in larger amounts 
than prescribed, for a longer period than prescribed, or use 
without a physician’s prescription. This definition casts a wider 
net, documenting the prevalence of PDM in the population as 
a whole, irrespective of motive. The goals of our study were 
to describe the prevalence of 12-month PDM in a population-
based Canadian sample and to examine the extent to which 
sociodemographic variables and other addictive behaviours 
were associated with this problem.
Method
Sample
A computer-aided telephone interview was administered to 
a random, representative sample of adults (n = 3511). Adults 
residing in private dwellings in Alberta were the target 
population. People living in group quarters (for example, 
rooming houses) and First Nations communities were 
excluded. Data were collected over a 2-month period in 2002. 
To participate, a respondent had to be a resident of the number 
called, be aged 18 years or older, and have the next birthday 
in the household. Households were selected using telephone 
numbers generated using random digit dialing. This process 
resulted in 6119 eligible screened numbers (that is, numbers 
that were not out of service, business, or fax numbers) from 
which 3511 respondents completed the full survey, 2553 
refused, and 55 did not complete the survey in full, resulting 
in a response rate of 57.4%. Calls were made across a range of 
times to reduce the possibility of selection bias by employment 
status (9 AM to 9 PM on weekdays, 10 AM to 4 PM on 
Saturdays,  and 2 PM to 8 PM on Sundays). Each household 
was contacted a maximum of 5 times. Sampling was stratified 
by region, with one-third drawn from Edmonton, Calgary, and 
the rest of the province. The mean interview length was 15 
minutes. Our study received approval from the University of 
Alberta’s Human Research Ethics Board and written informed 
consent was obtained from all participants. Data were weighted 
to correct for slight differences in the age and gender profile of 
respondents by region, compared with the Alberta 2001 census. 
All analyses were conducted on weighted data. Table 1 provides a 
description of the sample.
Measures
Prescription Drug Misuse
Four questions assessed PDM. Respondents were asked whether 
they had misused prescription opioids, sedatives, tranquilizers, 
or amphetamines in the 12 months preceding the interview, 
based on the following definition: use in larger amounts than 
prescribed, for a longer period than prescribed, or use without a 
physician’s prescription. Respondents who indicated that they 
had misused prescriptions in a specific drug class were asked to 
list the prescriptions they had misused in the past year.
Illicit Drug Use and Dependence
Additional items assessed use of cannabis, illicit amphetamines, 
hallucinogens, solvents, cocaine or crack, and heroin in the 
preceding 12 months. The 7-item CIDI-SF was used to assess 
drug dependence.17,18 Respondents met criteria for dependence 
if they scored positively on 4 or more items. Respondents with 
no past-year drug use were coded noncases. Scores ranged 
from 0 to 7 (mean 0.18, SD 0.81). The internal consistency of 
scores was good (α = 0.85).
Alcohol Use and Dependence
Three alcohol variables were examined: 12-month alcohol use 
(yes or no), frequent binge drinking (yes or no), and alcohol 
dependence. Consistent with other studies, frequent binge drinkers 
were defined as those who reported 5 or more drinks on one 
occasion once a month or more in the preceding year.19–21 
The 7-item CIDI-SF for alcohol was used to assess alcohol 
dependence.17,21 Respondents met criteria for dependence if 
Abbreviations used in this article
CIDI-SF			 Composite	International	Diagnostic	Interview—
Short	Form
NESARC			 National	Epidemiologic	Survey	on	Alcohol	and	
Related	Conditions
PGSI			 Problem	Gambling	Severity	Index
PDM			 prescription	drug	misuse	
VIF			 variance	inflation	factors
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they scored positively on 4 or more items, and those with no 
past-year use were coded noncases. Scores ranged from 0 to 
7 (mean 0.54, SD 1.12). Internal consistency of scores was 
acceptable (α = 0.68).
Smoking
Respondents were asked how frequently they smoked cigarettes 
in the past 30 days. Respondents who selected every day were 
coded daily smokers and those who selected almost every 
day, some days, or half days were coded nondaily smokers. 
Respondents who selected not at all were coded nonsmokers.
Problem Gambling
Problem gambling was assessed using the PGSI; a 9-item subset 
of the Canadian Problem Gambling Index that measures problem 
gambling in population-based samples.22 Problem gambling 
was defined by scores of 3 or more on the PGSI, and at-
risk gambling by scores of 1 to 2. Respondents reporting no 
gambling in the past year were coded noncases. In our study, 
PGSI scores ranged from 0 to 27 (mean 0.43, SD 2.12) and 
internal consistency was excellent (α = 0.90).
Demographic Covariates
Sex and age were assessed across 5 categories, marital status 
across 3 categories, education across 4 categories, employment 
and income across 6 categories, and region across 3 categories.
Data Analyses
The point prevalence of PDM was measured by calculating the 
proportion of the total sample who reported past-year PDM 
at a single point in 2002. All measures of prevalence were 
calculated using the total sample in keeping with the standard 
definition of prevalence in the epidemiologic literature23,24 and 
to ensure an accurate measure of disease burden in Alberta for 
the specified time point.
The degree to which 2 sets of variables (sociodemographics and 
addictive behaviours) were correlated with PDM was examined 
using logistic regression, with a dichotomous measure of 
PDM as the outcome and 95% confidence intervals. First, a 
hierarchal logistic regression model was estimated for 
sociodemographic variables. Significant variables were retained, 
as were 3 nonsignificant variables (age, sex, and region) for 
comparison with other studies. Next, addictive behaviours were 
entered simultaneously as one block, with the exception of alcohol 
variables. Alcohol predictors were then entered in separate 
blocks to accommodate the hierarchical relation between them 
(that is, to binge drink, alcohol must be consumed, and binge 
drinking typically occurs before a person becomes alcohol 
dependent). Multicollinearity between independent variables 
was examined using VIFs. All potential interactions were tested 
using log-likelihood statistics. Missing data were handled using 
listwise deletion. All analyses were run using SPSS software, 
version 17.0 (SPSS Inc, Chicago IL).25
Table 1  Description of the sample and 
unadjusted prevalence of 12-month PDM by 
sociodemographic characteristics
Characteristic
Total	unweighted	
n	(weighted	%)
Past-year	PDM		
n	(weighted	%)
Total	sample 3511	(100) 291	(8.2)
Sex
Male 1603	(49.4) 133	(8.2)
Female 1908	(50.6) 158	(8.2)
Age,	years
18–24 459	(13.5) 70	(14.8)
25–34 698	(19.7) 59	(8.3)
35–44 873	(24.0) 70	(7.9)
45–54 660	(18.4) 43	(6.4)
≥55 801	(24.4) 46	(5.8)
Marital	status
Married	or	cohabiting 2074	(59.7) 106	(12.6)
Not	currently	married 582	(16.4) 43	(7.0)
Never	married 854	(23.9) 142	(6.7)
Education
Some	high	school 474	(14.1) 35	(7.2)
High	school	diploma 729	(20.9) 86	(11.6)
Some	university	or	college 686	(19.4) 67	(9.8)
University	or	college	degree 1617	(45.7) 102	(6.1)
Employment	
Employed	full-	or	part-time 2610	(73.8) 183	(7.5)
Student 253	(6.9) 38	(15.2)
Homemaker 251	(6.7) 19	(7.7)
Retired 477	(14.6) 26	(5.9)
Unemployed 105	(3.1) 11	(11.1)
Disabled 62	(1.6) 13	(21.4)
Income,	$
<20	000 425	(13.9) 47	(11.0)
20	000–39	999 788	(25.4) 66	(7.8)
40	000–59	999		 693	(22.7) 58	(8.2)
60	000–79	999 455	(14.6) 41	(8.8)
80	000–99	999 262	(8.3) 22	(8.1)
≥100	000 453	(15.0) 37	(8.0)
Region
Edmonton 1171	(28.7) 117	(9.7)
Calgary 1172	(32.5) 93	(7.7)
Rest	of	province 1168	(38.8) 81	(7.4)
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Results
Prevalence
The unadjusted 12-month prevalence of PDM was 8.6%. To 
reduce misclassification error, PDM cases were asked to list 
prescriptions misused. Thirteen cases reported misuse of 
over-the-counter drugs exclusively (for example, Nytol and 
caffeine pills) and were recoded noncases. The corrected 
prevalence of PDM was 8.2% overall; and 4.9%, 2.6%, 
1.3%, and 0.8% for opiates, sedatives, amphetamines, and 
tranquilizers, respectively. Among PDMs, 86.3% misused 
prescriptions across 1 drug class, 10.9% across 2 drug classes, 
and 2.8% across 3 or more drug classes. Table 1 presents the 
prevalence of PDM by sociodemographic subgroup and Table 
2 by subgroups reporting various forms of addictive behaviour. 
Although 16.2% of PDMs met criteria for drug dependence, 
it could not be discerned whether these people were illicit or 
prescription drug dependent from the data collected. Almost 
one-half of respondents who met criteria for drug dependence 
(48.9%) reported PDM in the past year, compared with 7.0% of 
respondents who were not drug dependent.
Correlates of Prescription Drug Misuse
Table 3 presents odds of 12-month PDM by sociodemographic 
subgroup using adjusted odds ratios and 95% confidence 
intervals. No 2-way interactions were significant. The odds 
of PDM were statistically similar across regions of Alberta, 
men and women, and a range of household income brackets. 
PDM odds were greater among young adults in models 
adjusted for sociodemographic characteristics. However, other 
addictive behaviours were also more prevalent among young 
adults, compared with adults aged 25 years and older (illicit 
drug use: 34.3%, compared with 9.3%; alcohol dependence: 
10.6%, compared with 2.0%; and problem gambling: 6.6%, 
compared with 4.3%). Young adults were at no greater risk for 
PDM than older adults once other addictive behaviours were 
controlled in the model. This was also true for never-married 
respondents. In contrast, even in fully controlled models, 
respondents who reported their occupational status as disabled 
had 4 times greater odds of PDM than respondents employed 
full- or part-time. The odds of PDM also remained elevated 
for respondents with a high school diploma, relative to those 
with a post-secondary degree, and there was a trend toward 
significantly higher odds among respondents with some post-
secondary training that may prove significant in larger samples. 
Interestingly, student status itself was a significant predictor 
of PDM in fully controlled models. Models controlling for 
sociodemographics alone underestimated the strength of this 
association. Adults who recorded their primary occupation as 
student had almost 2 times greater odds of PDM than adults 
employed full- or part-time; 70% of these students were young 
adults (mean 24 years, SD 7.8, range 18 to 55 years).
Table 4 presents the odds of PDM by subgroups reporting 
various addictive behaviours. There was no evidence of multi-
collinearity across these variables (VIF 1.05 to 1.72) and no 
2-way interactions were significant. All forms of addictive 
behaviour were positively associated with PDM in models 
adjusted for sociodemographics. There were striking reductions 
in the magnitude and significance of these associations once 
confounding between PDM and other addictive behaviours 
was controlled. In a fully controlled model, smoking was no 
longer associated with PDM suggesting this relation was based 
on associations between smoking and other addictive problems 
rather than PDM itself. In contrast, even in fully controlled 
models, problem gamblers had almost 3 times greater odds 
of PDM than nonproblem gamblers. Comparatively, the odds 
of PDM among problem gamblers was higher than any other 
addictive correlate measured in our study. Categories of drugs 
most frequently misused by problem gamblers matched that 
of the general population, but prevalence was considerably 
higher in each drug class (12.8% opiates, 8.5% sedatives, 
5.5% stimulants, and 1.8% tranquilizers), odds of PDM were 
also higher among people using illicit drugs. Associations 
between PDM and cocaine use were stronger than cannabis or 
hallucinogen use (Table 4). Respondents who engaged in both 
PDM and illicit drug use in the past year (n = 98) were more 
likely to misuse prescriptions across multiple drug categories 
than respondents who misused prescription drugs alone 
(24.2% compared with 8.4% [χ2 = 13.37, df = 1, P < 0.001].
Overestimation of the association between binge drinking and 
PDM in models controlling for sociodemographics may have 
been due in part to moderately sized correlations between binge 
drinking and illicit drug use (φ = 0.35, P < 0.001). Alcohol 
Table 2  Unadjusted prevalence of 12-month 
PDM among respondents meeting criteria for 
12-month addictive behaviours
12-month	addictive	
behaviour
Total	unweighted	
n (weighted	%)
PDM	prevalence		
n (weighted	%)
Alcohol
	Alcohol	use 2923	(83.2) 267	(9.0)
≥Monthly	binge	drinking 506	(14.4) 73	(14.5)
Alcohol	dependent 108	(3.2) 33	(31.2)
Drugs
Any	illicit	drug	usea 451	(12.6) 98	(21.7)
Cannabis	use	 436	(12.1) 91	(20.7)
Cocaine	or	crack	use 59	(1.7) 25	(40.0)
Hallucinogen	use 65	(1.9) 23	(34.8)
Illicit	amphetamines 9	(0.2) 4	(42.9)
Solvents 18	(0.5) 10	(55.6)
Heroin 3	(0.1) 3	(100.0)
Drug	dependent 94	(2.7) 45	(48.9)
Smoking
Nondaily	smoker 198	(5.8) 26	(11.9)
Daily	smoker 758	(21.7) 85	(10.8)
Gambling
At-risk	gambling 220	(6.2) 27	(12.0)
Problem	gambling 167	(4.7) 36	(21.5)
a	Past-year	use	of	cannabis,	cocaine	or	crack,	hallucinogens,	illicit	amphetamines,	
solvents,	or	heroin
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use and alcohol dependence remained important predictors of 
PDM in fully controlled models. The odds of PDM for alcohol 
use without dependence was 1.74, while the odds for alcohol 
use with dependence was estimated at 1.74 × 2.20 = 3.94. The 
misuse of 2 or more classes of drugs was common among 
respondents with alcohol dependence who misused prescription 
drugs. Almost one-half (45.7%) of respondents with alcohol 
dependence misused prescriptions across 2 classes, compared 
with 9.2% of respondents who misused prescription drugs but 
did not have alcohol dependence (χ2 = 34.85, df = 1, P < 0.001).
Overall, the prevalence of PDM among respondents meeting 
criteria for 1 or more of problem gambling, alcohol dependence, 
or illicit drug use was more than 3 times that of respondents 
without these addictive problems (18.8%, compared with 
6.0%). Conversely, 43.7% of all respondents who misused 
prescription drugs met criteria for alcohol dependence, problem 
gambling, and (or) had used illicit drugs in the past year. One-
third of all respondents who misused prescription drugs had 
used illicit drugs in the past year, 12.4% were problem gamblers, 
and 12.0% were alcohol dependent.
Discussion
Our study examined the prevalence and correlates of PDM within 
a population-based sample of adults. Results indicate that in 
2002, 8.2% or 8200 adults per 100 000 in Alberta had misused 
1 or more prescription opiates, sedatives, amphetamines, 
or tranquilizers in the preceding 12 months. The overall 
prevalence of past-year opioid, sedative or tranquilizer, and 
stimulant misuse was 4.9%, 3.2%, and 0.8%, respectively. 
Among PDMs, 16.2% of respondents met criteria for illicit and 
(or) prescription drug dependence, compared with less than 1% 
of non-PDM respondents. Subpopulations at particular risk 
for PDM included disabled adults, adults with a high school 
diploma who had not pursued post-secondary studies, and 
adult students. Although the odds of PDM were particularly 
high among disabled adults, this finding was not surprising given 
they may use psychoactive prescriptions more frequently than the 
general population (for example, to control pain).26 Disabled 
adults are also more likely to have underlying comorbidities 
such as depression that further increase the potential for 
PDM.27,28 Targeted interventions aimed at reducing PDM 
among disabled adults should not hinder the necessary medical 
management of pain in this subpopulation. While high school 
graduates were 70% more likely to misuse prescriptions 
than university graduates, high school dropouts displayed no 
greater odds for this problem. It may be that adults who have 
not completed high school are less likely to visit a doctor, 
request or receive medications, or less likely to report PDM 
than high school graduates. Given the monotonic associations 
between education and PDM documented in US studies29,30 
further research is needed in Canada before more definitive 
conclusions can be made.
Confounding by other addictive behaviours masked higher 
odds of PDM among adult students. This association appears 
due in part to unique factors underlying the etiology of PDM 
among students, rather than factors typically shared by this 
subgroup, given these were controlled in the model (for 
example, young age or illicit drug use). There is evidence that 
US college students misuse prescriptions to relieve stress and 
improve concentration while studying, particularly in highly 
competitive academic environments.31–33 Further research is 
needed to examine motives for PDM among Canadian students.
Contrary to previous studies, age, marital status, and sex were 
not significant predictors of PDM.12,14,30,33,34 While young adults 
and never-married respondents displayed greater odds of PDM 
in initial models, these associations were no longer significant 
after other addictive behaviours were controlled, suggesting 
young adults and never-married respondents may have a higher 
Table 3  AORs of 12-month PDM by 
sociodemographic characteristicsa
Characteristic AORb	(95%	CI) AORc		(95%	CI)
Sex
Male 1.09	(0.84–1.41) 0.91	(0.69–1.21)
Female 1.0	(Reference) 1.0	(Reference)
Age,	years
18–24 1.81	(1.01–3.29)a 1.12	(0.59–2.14)
25–34 1.37	(0.80–2.35) 1.08	(0.61–1.91)
35–44 1.36	(0.82–2.27) 1.21	(0.71–2.07)
45–54 1.06	(0.62–1.82) 1.00	(0.57–1.76)
≥55 1.0	(Reference) 1.0	(Reference)
Marital	Status
Married	or	cohabiting 1.0	(Reference) 1.0	(Reference)
Not	currently	married 1.05	(0.71–1.54) 0.94	(0.63–1.40)
Never	married 1.40	(1.01–1.97)a 1.02	(0.70–1.48)
Education
Some	high	school 1.13	(0.74–1.73) 0.93	(0.59–1.46)
High	school	diploma 1.84	(1.34–2.53)a 1.70	(1.22–2.38)a
Some	university	or	college 1.40	(1.01–1.98)a 1.26	(0.88–1.81)
University	or	college	degree 1.0	(Reference) 1.0	(Reference)
Employment	
Employed	full-	or	part-time 1.0	(Reference) 1.0	(Reference)
Student 1.35	(0.85–2.13) 1.86	(1.14–3.05)a
Homemaker 1.17	(0.69–2.03) 1.36	(0.78–2.35)
Retired 1.03	(0.58–1.86) 1.26	(0.69–2.31)
Unemployed 1.39	(0.74–2.60) 1.50	(0.77–2.92)
Disabled 3.99	(2.01–7.94)a 4.01	(1.96–8.23)a
Region
Edmonton 1.32	(0.97–1.77) 1.27	(0.93–1.74)
Calgary 1.05	(0.77–1.42) 0.98	(0.71–1.36)
Rest	of	province 1.0	(Reference) 1.0	(Reference)
a	Significant	ORs
b	Adjusted	for	sex,	age,	marital	status,	education,	employment,	and	region
c	Adjusted	for	past-year	alcohol	use,	alcohol	dependence,	smoking,	problem	
gambling,	past-year	cannabis	use,	cocaine	or	crack	use,	and	hallucinogen	
use
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propensity for addictive behaviours correlated with PDM, but 
no greater odds of PDM itself. As well, men had no greater odds 
of PDM than women. Using a definition of PDM matching our 
study, data derived from the 2001–2002 US NESARC study 
found lifetime PDM was more common among men across all 
categories of psychoactive prescription drugs.13 Data from the 
2003 US National Survey on Drug Use and Health found 12 
month nonmedical opioid use (that is, without a prescription 
or for the feeling it caused) was also more common among 
men, while women were equally likely to misuse sedatives, 
tranquilizers, or stimulants.35 Further research is needed 
to gain a better understanding of PDM by sex in Canada, 
including experiences that contribute to this problem across 
the life course. Clinical studies suggest affective stress and 
a history of sexual or physical abuse are risk factors for 
prescription opioid misuse in women, while criminal behaviour 
and associating with substance abusers are risk factors for 
men.36–38 A population-based assessment of factors that precede 
PDM in Canada would make a significant contribution to our 
understanding of this problem.
Our study was among the first to examine associations between 
problem gambling and PDM in a population-based sample. The 
odds of PDM among problem gamblers was almost 3 times 
greater than nonproblem gamblers. Almost one-quarter of problem 
gamblers who misused prescriptions did so over 2 or more drug 
categories, increasing the likelihood for adverse consequences. 
Problem gamblers may be misusing prescriptions to cope with 
gambling losses, deal with gambling urges, to stay awake while 
gambling, or they may engage in both PDM and gambling to 
escape other life stressors. Further research is needed to shed more 
light on motives for PDM among problem gamblers.
While the NESARC study found lifetime smoking and 
lifetime PDM were associated in models adjusted for 
sociodemographics,13 our study found additional control for 
other addictive behaviours negates this relation for 12-month 
behaviour. Findings suggest any association between smoking 
and PDM was a product of strong relations between smoking 
and other addictive behaviours rather than PDM itself. Future 
studies that separate PDM by motive (for example, to relieve 
pain or to get high) are needed to understand this relation in a 
more detailed way.
Despite the significant risk to increased morbidity and mortality, 
studies suggest the substance most frequently used in combination 
with prescription drugs is alcohol.39 Our study found alcohol 
use was a risk factor for PDM, but this association was stronger 
for alcohol dependence than alcohol use alone. PDM among 
alcohol-dependent respondents frequently involved misuse 
across multiple prescription drug categories, increasing the risk 
for adverse consequences. Binge drinking, in contrast, did not 
increase the odds of PDM in fully controlled models. Similar 
to young adults and unmarried respondents, binge drinkers 
appeared to have a propensity for at-risk addictive behaviours 
highly correlated with PDM (for example, illicit drug use) 
rather than a specific proclivity for PDM itself.
Consistent with previous studies, illicit drug use was highly 
associated with PDM.33,35,40 Almost one-quarter of respondents 
who used illicit drugs in the past year had also misused 
prescriptions in that time period. Associations between PDM 
and cocaine or crack use were stronger than cannabis or 
hallucinogen use.
More generally, many people who engage in addictive 
behaviours do so in complex ways that amplify the likelihood 
of PDM beyond the single odds ratios presented here. For 
example, single odds ratios do not take into account that most 
Table 4  AORs of 12-month PDM by comorbid 
addictive behaviour
12-month	addictive	
behaviour AORa		(95%	CI) AORb	(95%	CI)
Alcohol	use
No 1.0	(Reference) 1.0	(Reference)
Yes 2.22	(1.42–3.47)c 1.81	(1.15–2.86)c
≥Monthly	binge	drinking
No 1.0	(Reference) 1.0	(Reference)
Yes 1.79	(1.30–2.47)c 0.89	(0.60–1.32)
Alcohol	dependence
No 1.0	(Reference) 1.0	(Reference)
Yes 4.29	(2.72–6.77)c 2.19	(1.28–3.74)c
Cannabis	use	
No 1.0	(Reference) 1.0	(Reference)
Yes 3.15	(2.30–4.32)c 2.02	(1.39–2.94)c
Cocaine	or	crack	use
No 1.0	(Reference) 1.0	(Reference)
Yes 5.67	(3.20–10.05)c 2.71	(1.42–5.16)c
Hallucinogen	use
No 1.0	(Reference) 1.0	(Reference)
Yes 4.47	(2.53–7.91)c 1.91	(1.01–3.63)c
Smoking
None 1.0	(Reference) 1.0	(Reference)
Nondaily	smoker 1.55	(0.98–2.47) 1.04	(0.63–1.72)
Daily	smoker 1.43	(1.06–1.91)c 0.95	(0.69–1.32)
Gambling
Nonproblem	gambler 1.0	(Reference) 1.0	(Reference)
At-risk	gambler 1.55	(0.99–2.41) 1.53	(0.96–2.43)
Problem	gambler 3.24	(2.15–4.88)c 2.92	(1.88–4.53)c
a	
Adjusted	for	sex,	age,	marital	status,	education,	employment,	and	region	
b	
Adjusted	for	past-year	alcohol	use,	alcohol	dependence,	smoking,	
problem	gambling,	past-year	cannabis	use,	cocaine	or	crack	use,	and	
hallucinogen	use		
c	Significant	ORs
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adults who use cannabis also use alcohol, amplifying the true 
odds of PDM among most cannabis users to 2.02 × 1.81 = 
3.66. Similarly, cocaine or crack use in the past year without 
cannabis and alcohol use in the past year is rare, amplifying the 
odds of PDM for most cocaine or crack users to 2.71 × 2.02 × 
1.81 = 9.91.
Our study had several limitations. Information about prescription 
drug use, motives for misuse, prescription drug dependence, and 
correlates of PDM in previous studies (for example, depression, 
anxiety, and physical illness) were not collected. Second, 
although research suggests sociodemographic factors may be 
uniquely associated with the specific drug class misused,41 the 
sample size could not accommodate analyses by drug category. 
Third, the cross-sectional design precludes inferences about 
causation and temporal sequence. Finally, there may be response 
bias, owing to the relatively low response rate, use of self-report 
measures, and the use of telephone interviewing. 
Conclusions
PDM was an important public health concern in Alberta in 
2002. At that time, Canada reported the fourth highest per capita 
consumption of prescription narcotics in the world.42 In 2009, 
Canada became the third highest per capita user, with estimates 
for prescription opiate misuse growing 24.3% between 
2002 and 2005 alone.43,44 There is an urgent need for an ongoing 
assessment of this evolving problem. Despite its limited geographic 
locale, our work extends current knowledge about PDM in Canada 
and provides epidemiologic information that can be used to 
compare and complement future research in this area.
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Résumé : Prévalence et corrélats du mésusage de 12 mois des médicaments sur 
ordonnance en Alberta
Objectif :	Nous	avons	examiné	la	prévalence	et	les	corrélats	du	mésusage	des	médicaments	sur	
ordonnance	(MMO)	dans	un	échantillon	d’adultes	de	la	population	de	l’Alberta.	
Méthodes : Les	données	ont	été	recueillies	auprès	de	3511	adultes	de	l’Alberta	âgés	de	18	ans	et	
plus	en	2002,	au	moyen	d’un	sondage	téléphonique	assisté	par	ordinateur.	Le	taux	de	réponse	a	
été	de	57,4	%.
Résultats : La	prévalence	de	12	mois	du	MMO	en	Alberta	était	de	8,2	%	en	2002.	Les	opiacés	
étaient	la	classe	de	médicaments	la	plus	fréquemment		mal	utilisée,	suivis	des	sédatifs,	stimulants,	
et	tranquillisants.	L’incapacité	en	cours	était	particulièrement	associée	au	MMO.	Les	probabilités	
de	MMO	étaient	aussi	élevées	chez	les	adultes	étudiants	et	chez	les	adultes	détenant	un	diplôme	
d’études	secondaires,	relativement	aux	adultes	titulaires	d’un	diplôme	d’études	postsecondaires.	
Les	problèmes	de	jeu,	l’utilisation	de	drogues	illicites,	et	la	consommation	et	la	dépendance	à	
l’alcool	dans	l’année	précédente	étaient	tous	associés	au	MMO,	alors	que	la	consommation	
excessive	d’alcool	et	l’usage	quotidien	du	tabac	ne	l’étaient	pas.	
Conclusions : Les	résultats	suggèrent	que	le	MMO	était	un	important	problème	de	santé	publique	
en	Alberta,	en	2002.	Les	estimations	suggèrent	que	l’usage	et	le	mésusage	des	ordonnances	
ont	augmenté	substantiellement	au	Canada	depuis	ce	temps.	Il	y	a	un	besoin	pressant	d’une	
évaluation	continue	de	ce	problème	croissant	de	sorte	que	des	stratégies	préventives	et	
thérapeutiques	efficaces	puissent	être	élaborées.	
